The Tactical–Commercial Distinction: 2,4,5-T, TCDD, and the Recognition of War-Related Health Harm in the Panama Canal Zone
DOI:
https://doi.org/10.66659/dgzstm97Keywords:
Panama Canal Zone; veterans’ health claims; 2,4,5-T; TCDD; Agent Orange; herbicide exposure; war-related contamination; military pollution; toxicology; exposure pathways; institutional responsibilityAbstract
This paper examines the Panama Canal Zone as an underrecognized case of potential military-related herbicide exposure and delayed health recognition among United States veterans. It focuses on 2,4,5-T and its contaminant 2,3,7,8-TCDD, a persistent dioxin associated with phenoxy-herbicide manufacture. Rather than accepting the “tactical” versus “commercial” distinction as merely administrative, the paper asks how this classification has shaped interpretations of fragmented evidence concerning contamination, exposure pathways, and veterans’ health claims.
Using a historical-documentary and conceptual approach, the study integrates toxicological evidence, military and herbicide-use records, veterans’ accounts, geographic context, health outcomes, and institutional criteria for recognizing exposure-related harm. These materials are organized in an evidence map designed to assess incomplete but converging evidence without treating historical plausibility as proof or fragmented records as grounds for dismissal.
The paper argues that the tactical–commercial distinction may obscure toxicological and historical continuities relevant to long-term exposure, latency, and institutional responsibility. Its contribution is twofold: it establishes the Panama Canal Zone as a significant case for war-and-health research beyond the conventional Vietnam-centered Agent Orange framework, and it proposes a method for reconstructing evidence where exposure is historically plausible and toxicologically significant but administratively difficult to recognize.
References
Published
Issue
Section
Categories
- Chemical Pollution in Indochina
- Conferences and Events
- Conference in Prague, October 15–17, 2026
- Environmental Risks and Disasters
- War-Related Environmental Impacts
- Health and Diseases
- Biomonitoring and Exposure Science
- Cancer and Chronic Diseases
- Health Effects of War and Conflict
- Toxicology and Risk Assessment